Glenmark Life Sciences Ltd 543322
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 827.75
- Day Range
- INR 827.10–838.90
- 52-Week Range
- INR 512.70–904.20
- Bid/Ask
- INR 0.00 / INR 0.00
- Market Cap
- INR 102.05 Bil
- Volume/Avg
- 2,611 / 9,498
Key Statistics
- Price/Earnings (Normalized)
- 21.56
- Price/Sales
- 4.45
- Dividend Yield (Trailing)
- 2.70%
- Dividend Yield (Forward)
- 2.70%
- Total Yield
- 2.72%
Company Profile
Glenmark Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disease, pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 3,285
Comparables
Valuation
|
Metric
|
543322
|
543434
|
524348
|
|---|---|---|---|
Price/Earnings (Normalized) | 21.56 | 24.76 | 26.49 |
Price/Book Value | 4.35 | 4.02 | 3.52 |
Price/Sales | 4.45 | 5.56 | 1.78 |
Price/Cash Flow | 18.60 | 28.27 | 20.04 |
Price/Earnings
543322
543434
524348
Financial Strength
|
Metric
|
543322
|
543434
|
524348
|
|---|---|---|---|
Quick Ratio | 2.64 | 3.14 | 0.91 |
Current Ratio | 4.37 | 6.26 | 1.66 |
Interest Coverage | 409.34 | 192.48 | 8.03 |
Quick Ratio
543322
543434
524348
Profitability
|
Metric
|
543322
|
543434
|
524348
|
|---|---|---|---|
Return on Assets (Normalized) | 16.82% | — | 7.10% |
Return on Equity (Normalized) | 20.87% | — | 13.89% |
Return on Invested Capital (Normalized) | 20.73% | — | 10.74% |
Return on Assets
543322
543434
524348
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Cgqyvtqqsz | Prspw | $79.9 Bil | |
ZTS
| Zoetis Inc Class A | Gpzwhglhs | Gmcx | $79.3 Bil | |
HLN
| Haleon PLC ADR | Pdmpwmrrz | Lvr | $38.1 Bil | |
VTRS
| Viatris Inc | Bpfsmvbw | Rdqm | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Hhztywf | Wstz | $11.7 Bil | |
CTLT
| Catalent Inc | Msnhtzqd | Rtzgw | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Bnnwzfhkb | Crdp | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Gnjrympv | Snxrj | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Zyhxqdrnf | Ymlmqs | $3.2 Bil | |
GTBIF
| Green Thumb Industries Inc | Rstxtgqb | Vqgz | $3.1 Bil |